Author： Fosker Christopher
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.71, Iss.15, 2011-10, pp. : 1947-1955
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacogenetically Driven Treatments for Alcoholism: Are We There Yet?
By Arias Albert J. Sewell R. Andrew
CNS Drugs, Vol. 26, Iss. 6, 2012-06 ,pp. :
Access to resources
Recommend
Anastrozole: first-line therapy for advanced breast cancer?
Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. :
Is it worth using lapatinib for advanced breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. :
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
Dasatinib: a novel therapy for breast cancer?
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. :